Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,711,000 | 5,488,000 | 5,840,000 | 6,166,000 | 6,329,000 |
| Marketable Securities | 120,000 | 220,000 | 238,000 | 326,000 | 152,000 |
| Receivables | 16,335,000 | 14,831,000 | 13,552,000 | 11,252,000 | 10,307,000 |
| Inventories | 6,557,000 | 5,288,000 | 5,424,000 | 4,699,000 | 8,983,000 |
| Other current assets | 0 | 0 | 0 | 150,000 | 473,000 |
| TOTAL | $28,723,000 | $25,827,000 | $25,054,000 | $22,593,000 | $26,244,000 |
| Non-Current Assets | |||||
| PPE Net | 12,962,000 | 10,252,000 | 9,402,000 | 8,507,000 | 9,183,000 |
| Investments And Advances | 3,023,000 | 2,082,000 | 1,905,000 | 1,216,000 | 1,339,000 |
| Intangibles | 59,088,000 | 58,202,000 | 58,137,000 | 59,127,000 | 62,384,000 |
| Other Non-Current Assets | 10,278,000 | 7,672,000 | 6,621,000 | 5,040,000 | 6,213,000 |
| TOTAL | $85,351,000 | $78,208,000 | $76,065,000 | $73,890,000 | $79,119,000 |
| Total Assets | $114,074,000 | $104,035,000 | $101,119,000 | $96,483,000 | $105,363,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,104,000 | 2,337,000 | 5,129,000 | 5,314,000 | 1,660,000 |
| Accounts payable and accrued liabilities | 25,280,000 | 22,465,000 | 22,374,000 | 19,040,000 | 18,938,000 |
| Other current liabilities | 767,000 | 1,319,000 | 1,184,000 | 815,000 | 847,000 |
| TOTAL | $30,617,000 | $27,866,000 | $30,542,000 | $26,293,000 | $22,594,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,715,000 | 26,506,000 | 22,365,000 | 22,965,000 | 28,134,000 |
| Other Non-Current Liabilities | 6,515,000 | 5,481,000 | 6,196,000 | 7,218,000 | 9,139,000 |
| TOTAL | $34,738,000 | $35,298,000 | $31,411,000 | $33,132,000 | $43,482,000 |
| Total Liabilities | $65,355,000 | $63,164,000 | $61,953,000 | $59,425,000 | $66,076,000 |
| Shareholders' Equity | |||||
| Common Shares | 388,000 | 388,000 | 388,000 | 387,000 | 387,000 |
| Retained earnings | 10,972,000 | 3,160,000 | 1,502,000 | -574,000 | 1,710,000 |
| Other shareholders' equity | 2,093,000 | 2,097,000 | 2,088,000 | 2,090,000 | 2,064,000 |
| TOTAL | $48,719,000 | $40,871,000 | $39,166,000 | $37,058,000 | $39,287,000 |
| Total Liabilities And Equity | $114,074,000 | $104,035,000 | $101,119,000 | $96,483,000 | $105,363,000 |